The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Botanical Supplement and Drug Market Research Report 2024

Global Botanical Supplement and Drug Market Research Report 2024

Publishing Date : Jun, 2023

License Type :
 

Report Code : 1737714

No of Pages : 100

Synopsis
Botanical dietary supplements, sometimes called herbals or herbal dietary supplements, are products made from plants, plant parts, or plant extracts. They are meant to be consumed and contain one or more ingredients meant to supplement the diet.
Global Botanical Supplement and Drug market is projected to reach US$ 30660 million in 2029, increasing from US$ 19250 million in 2022, with the CAGR of 6.9% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Botanical Supplement and Drug market research.
Key companies engaged in the Botanical Supplement and Drug industry include Buchang Pharmaceuticals, China TCM, Tsumura, Schwabe, Tong Ren Tang, Jumpcan Pharmaceutical, Guangzhou Baiyunshan Pharmaceutical, Yunnan Baiyao and Tasly Holding Group, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Botanical Supplement and Drug were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Botanical Supplement and Drug market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Botanical Supplement and Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Buchang Pharmaceuticals
China TCM
Tsumura
Schwabe
Tong Ren Tang
Jumpcan Pharmaceutical
Guangzhou Baiyunshan Pharmaceutical
Yunnan Baiyao
Tasly Holding Group
Bionorica Se
Huarun 999
Taiji
Weleda
Kwangdong
GW Pharmaceuticals
Segment by Type
Drugs
Food and Beverages
Cosmetics
Segment by Application
Hospital
Retail Pharmacy
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Botanical Supplement and Drug report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Botanical Supplement and Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Drugs
1.2.3 Food and Beverages
1.2.4 Cosmetics
1.3 Market by Application
1.3.1 Global Botanical Supplement and Drug Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Botanical Supplement and Drug Market Perspective (2018-2029)
2.2 Botanical Supplement and Drug Growth Trends by Region
2.2.1 Global Botanical Supplement and Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Botanical Supplement and Drug Historic Market Size by Region (2018-2023)
2.2.3 Botanical Supplement and Drug Forecasted Market Size by Region (2024-2029)
2.3 Botanical Supplement and Drug Market Dynamics
2.3.1 Botanical Supplement and Drug Industry Trends
2.3.2 Botanical Supplement and Drug Market Drivers
2.3.3 Botanical Supplement and Drug Market Challenges
2.3.4 Botanical Supplement and Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Botanical Supplement and Drug Players by Revenue
3.1.1 Global Top Botanical Supplement and Drug Players by Revenue (2018-2023)
3.1.2 Global Botanical Supplement and Drug Revenue Market Share by Players (2018-2023)
3.2 Global Botanical Supplement and Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Botanical Supplement and Drug Revenue
3.4 Global Botanical Supplement and Drug Market Concentration Ratio
3.4.1 Global Botanical Supplement and Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Botanical Supplement and Drug Revenue in 2022
3.5 Botanical Supplement and Drug Key Players Head office and Area Served
3.6 Key Players Botanical Supplement and Drug Product Solution and Service
3.7 Date of Enter into Botanical Supplement and Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Botanical Supplement and Drug Breakdown Data by Type
4.1 Global Botanical Supplement and Drug Historic Market Size by Type (2018-2023)
4.2 Global Botanical Supplement and Drug Forecasted Market Size by Type (2024-2029)
5 Botanical Supplement and Drug Breakdown Data by Application
5.1 Global Botanical Supplement and Drug Historic Market Size by Application (2018-2023)
5.2 Global Botanical Supplement and Drug Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Botanical Supplement and Drug Market Size (2018-2029)
6.2 North America Botanical Supplement and Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Botanical Supplement and Drug Market Size by Country (2018-2023)
6.4 North America Botanical Supplement and Drug Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Botanical Supplement and Drug Market Size (2018-2029)
7.2 Europe Botanical Supplement and Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Botanical Supplement and Drug Market Size by Country (2018-2023)
7.4 Europe Botanical Supplement and Drug Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Botanical Supplement and Drug Market Size (2018-2029)
8.2 Asia-Pacific Botanical Supplement and Drug Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Botanical Supplement and Drug Market Size by Region (2018-2023)
8.4 Asia-Pacific Botanical Supplement and Drug Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Botanical Supplement and Drug Market Size (2018-2029)
9.2 Latin America Botanical Supplement and Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Botanical Supplement and Drug Market Size by Country (2018-2023)
9.4 Latin America Botanical Supplement and Drug Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Botanical Supplement and Drug Market Size (2018-2029)
10.2 Middle East & Africa Botanical Supplement and Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Botanical Supplement and Drug Market Size by Country (2018-2023)
10.4 Middle East & Africa Botanical Supplement and Drug Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Buchang Pharmaceuticals
11.1.1 Buchang Pharmaceuticals Company Detail
11.1.2 Buchang Pharmaceuticals Business Overview
11.1.3 Buchang Pharmaceuticals Botanical Supplement and Drug Introduction
11.1.4 Buchang Pharmaceuticals Revenue in Botanical Supplement and Drug Business (2018-2023)
11.1.5 Buchang Pharmaceuticals Recent Development
11.2 China TCM
11.2.1 China TCM Company Detail
11.2.2 China TCM Business Overview
11.2.3 China TCM Botanical Supplement and Drug Introduction
11.2.4 China TCM Revenue in Botanical Supplement and Drug Business (2018-2023)
11.2.5 China TCM Recent Development
11.3 Tsumura
11.3.1 Tsumura Company Detail
11.3.2 Tsumura Business Overview
11.3.3 Tsumura Botanical Supplement and Drug Introduction
11.3.4 Tsumura Revenue in Botanical Supplement and Drug Business (2018-2023)
11.3.5 Tsumura Recent Development
11.4 Schwabe
11.4.1 Schwabe Company Detail
11.4.2 Schwabe Business Overview
11.4.3 Schwabe Botanical Supplement and Drug Introduction
11.4.4 Schwabe Revenue in Botanical Supplement and Drug Business (2018-2023)
11.4.5 Schwabe Recent Development
11.5 Tong Ren Tang
11.5.1 Tong Ren Tang Company Detail
11.5.2 Tong Ren Tang Business Overview
11.5.3 Tong Ren Tang Botanical Supplement and Drug Introduction
11.5.4 Tong Ren Tang Revenue in Botanical Supplement and Drug Business (2018-2023)
11.5.5 Tong Ren Tang Recent Development
11.6 Jumpcan Pharmaceutical
11.6.1 Jumpcan Pharmaceutical Company Detail
11.6.2 Jumpcan Pharmaceutical Business Overview
11.6.3 Jumpcan Pharmaceutical Botanical Supplement and Drug Introduction
11.6.4 Jumpcan Pharmaceutical Revenue in Botanical Supplement and Drug Business (2018-2023)
11.6.5 Jumpcan Pharmaceutical Recent Development
11.7 Guangzhou Baiyunshan Pharmaceutical
11.7.1 Guangzhou Baiyunshan Pharmaceutical Company Detail
11.7.2 Guangzhou Baiyunshan Pharmaceutical Business Overview
11.7.3 Guangzhou Baiyunshan Pharmaceutical Botanical Supplement and Drug Introduction
11.7.4 Guangzhou Baiyunshan Pharmaceutical Revenue in Botanical Supplement and Drug Business (2018-2023)
11.7.5 Guangzhou Baiyunshan Pharmaceutical Recent Development
11.8 Yunnan Baiyao
11.8.1 Yunnan Baiyao Company Detail
11.8.2 Yunnan Baiyao Business Overview
11.8.3 Yunnan Baiyao Botanical Supplement and Drug Introduction
11.8.4 Yunnan Baiyao Revenue in Botanical Supplement and Drug Business (2018-2023)
11.8.5 Yunnan Baiyao Recent Development
11.9 Tasly Holding Group
11.9.1 Tasly Holding Group Company Detail
11.9.2 Tasly Holding Group Business Overview
11.9.3 Tasly Holding Group Botanical Supplement and Drug Introduction
11.9.4 Tasly Holding Group Revenue in Botanical Supplement and Drug Business (2018-2023)
11.9.5 Tasly Holding Group Recent Development
11.10 Bionorica Se
11.10.1 Bionorica Se Company Detail
11.10.2 Bionorica Se Business Overview
11.10.3 Bionorica Se Botanical Supplement and Drug Introduction
11.10.4 Bionorica Se Revenue in Botanical Supplement and Drug Business (2018-2023)
11.10.5 Bionorica Se Recent Development
11.11 Huarun 999
11.11.1 Huarun 999 Company Detail
11.11.2 Huarun 999 Business Overview
11.11.3 Huarun 999 Botanical Supplement and Drug Introduction
11.11.4 Huarun 999 Revenue in Botanical Supplement and Drug Business (2018-2023)
11.11.5 Huarun 999 Recent Development
11.12 Taiji
11.12.1 Taiji Company Detail
11.12.2 Taiji Business Overview
11.12.3 Taiji Botanical Supplement and Drug Introduction
11.12.4 Taiji Revenue in Botanical Supplement and Drug Business (2018-2023)
11.12.5 Taiji Recent Development
11.13 Weleda
11.13.1 Weleda Company Detail
11.13.2 Weleda Business Overview
11.13.3 Weleda Botanical Supplement and Drug Introduction
11.13.4 Weleda Revenue in Botanical Supplement and Drug Business (2018-2023)
11.13.5 Weleda Recent Development
11.14 Kwangdong
11.14.1 Kwangdong Company Detail
11.14.2 Kwangdong Business Overview
11.14.3 Kwangdong Botanical Supplement and Drug Introduction
11.14.4 Kwangdong Revenue in Botanical Supplement and Drug Business (2018-2023)
11.14.5 Kwangdong Recent Development
11.15 GW Pharmaceuticals
11.15.1 GW Pharmaceuticals Company Detail
11.15.2 GW Pharmaceuticals Business Overview
11.15.3 GW Pharmaceuticals Botanical Supplement and Drug Introduction
11.15.4 GW Pharmaceuticals Revenue in Botanical Supplement and Drug Business (2018-2023)
11.15.5 GW Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’